Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 201Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Year : 2013  |  Volume : 4  |  Issue : 2  |  Page : 148-152

Pharmacovigilance Symposium ISCR Annual Conference Jan 5, 2013: Safety aspects of hard endpoint or outcome trials

1 Hallmark Business Plaza, Gurunanak Hospital Road, Near Gurunanak Hospital, Bandra (East), Mumbai, India
2 VP Medical and Head Asia Medical Sciences Group, Quintiles Research Private Limited, Bangalore, Karnataka, India
3 Department of Digestive Diseases, Tata Medical Center, Kolkata, West Bengal, India

Correspondence Address:
Indu Nambiar
1002, 10th Floor, Hallmark Business Plaza, Near Gurunanak Hospital, Bandra (East), Mumbai - 400 051
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2229-3485.111801

Rights and Permissions

The articles describes some highlights of the Pharmacovigilance Symposium held during Annual conference.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded322    
    Comments [Add]    

Recommend this journal